FDA Approves TRETINOIN — Encube Ethicals, Inc.

# FDA Approves Encube Ethicals' Generic Tretinoin Topical Formulation The U.S. Food and Drug Administration has approved Encube Ethicals, Inc.'s abbreviated new drug application for a generic tretinoin topical formulation (ANDA217833), expanding the competitive landscape in the acne and anti-aging treatment market and potentially reducing patient costs for this widely-prescribed retinoid therapy. The approval introduces additional generic competition to the tretinoin topical market, which could pressure pricing while broadening patient access to this established dermatological agent.